admin – Page 7016 – Get News Story

Dr. Jamilia R. Howard Named Marquis Who’s Who in America Listee

“Dr. Jamilia R. Howard, Chief Academic Officer at The Continents States University”

St. Louis, Missouri – Dr. Jamilia R. Howard, a distinguished education professional and executive at The Continents States University, has been recognized as a Marquis Who’s Who in America listee. Dr. Howard’s inclusion in this list follows in the footsteps of colleagues at The Continents States University such as Dean of Graduate Studies, Dr. Pradeep Ganguly, and President Dr. Ricky Madison.

With over 16 years of experience in the education sector, Dr. Howard has demonstrated exemplary leadership and dedication to advancing educational practices. Her journey in education began as a classroom teacher within Georgia’s Mitchell County School District, where she taught a variety of subjects to students and licensed from grades Pre-K-6. She has served in many leadership capacities; Georgia Leadership Institute for School Improvement (GLISI), SACS accreditation committee, Leadership Cohort I & II, and Grade-chairperson to name a few. Notably, her commitment to excellence earned her the distinction of Teacher of the Year for the school and county during the 2012-2013 academic year.

Throughout her career, Dr. Howard has continually sought opportunities to enhance her impact within the educational landscape. She transitioned into school administration, serving as Assistant Director at Open Door Learning Center, where she played a pivotal role in managing operations, curriculum development, and staff supervision. Dr. Howard’s expertise in educational programming and operations was further honed during her tenure as Educational Director at Sunshine Learning Center in the Bronx, New York, where she spearheaded initiatives in STEM/STEAM education, curriculum enhancements, and staff development.

In addition to her professional roles, Dr. Howard has been actively involved in academia, serving as a university adjunct professor educating college freshman in child and human development and post graduate students in community based learning. She has also served as Director of Programs & Family Engagement at the National Children’s Center in Washington, D.C. Her commitment to advancing educational outcomes extends beyond the classroom, as she actively volunteers with organizations such as the Girl Scouts, further exemplifying her dedication to community engagement and empowerment.

Dr. Howard’s recognition as a Marquis Who’s Who in America listee underscores her significant contributions to the field of education and her ongoing commitment to fostering excellence in teaching and learning. Her inclusion in this esteemed list solidifies her position as a trailblazer and thought leader within the education community.

Moreover, Dr. Howard has been instrumental in leading The Continents States University as its Chief Academic Officer, where she has implemented innovative educational strategies and initiatives aimed at enhancing student success and academic excellence.

For media inquiries or to schedule an interview with Dr. Jamilia R. Howard, please contact:

Dr. Jamilia Howard

Media Contact
Company Name: The Continents States University
Contact Person: Office of Outreach and Relationships
Email: Send Email
Country: United States
Website: https://www.continents.us/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dr. Jamilia R. Howard Named Marquis Who\’s Who in America Listee

Revolutionizing Medical Histories: Treatment AI’s (CSE: TRUE) Pioneering Approach to Culturally Sensitive Data Collection

“Health Care AI Stocks”

Within the field of artificial intelligence (AI), generative AI is rapidly transforming the healthcare sector. Generative AI models are able to create new data instances that bear a striking resemblance to real healthcare data by utilizing sophisticated machine learning methods. These cutting-edge methods have the power to completely change a number of healthcare-related fields, including medication development, patient care, and disease detection and diagnosis.

In a significant leap forward for digital healthcare, Vancouver-based Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) has proudly announced its receipt of funding from The National Institute of Health (NIH) to develop an innovative, culturally sensitive artificial intelligence (AI) approach to collecting family medical histories. This pioneering project, in partnership with Rush River Research in Minneapolis, is set to revolutionize how medical information is gathered, particularly for African-American families.

Bridging the Gap in Medical Data Collection

The conventional methods clinicians use to collect family medical histories often fall short when it comes to adequately capturing crucial information from blended families or non-traditional relationships, which are prevalent in racial or ethnic minority communities. This shortfall is even more pronounced in African-American communities, where historical trauma and systemic bias may limit the available information about relatives’ health. Treatment.com’s initiative aims to address these disparities head-on, using AI to refine and improve the way health data is collected and recorded.

A Culturally Sensitive Approach

Recognizing the unique challenges faced by African-American families, Treatment.com and Rush River Research have engaged directly with the community, organizing multiple focus groups with African American doctors and community members. These discussions have been instrumental in developing and prototyping culturally sensitive methods to collect family health information, ensuring that the AI platform can accommodate the nuances of diverse family structures and histories.

Towards a Fairer Future in Healthcare

As part of its commitment to reducing health inequity, Treatment.com is also focused on building the world’s most comprehensive and integrated online medical library powered by AI — the Global Library of Medicine. This ambitious project aims to ensure that future diagnostic and treatment information provided by AI platforms is free from the biases currently reflected in medical AI programs. By involving African-American voices in the evaluation and improvement of the Treatment platform, the company is ensuring that a broad and diverse perspective informs the continuous enhancement of its technology.

From Prototype to Commercial Solution

The initial prototype for the family history solution has been seamlessly integrated into the Treatment AI platform. With ongoing enhancements, this solution will be rigorously tested and implemented in future iterations of the Global Library of Medicine platform. Following this successful development phase, Treatment and Rush River Research have submitted an expanded Phase 2 grant proposal to the NIH. The aim is to evolve the prototype into a commercial solution that can be widely adopted and integrated into electronic health records and online applications.

A Visionary Statement

Kevin Peterson MD, MPH, FRCS(Ed), FAAFP, Chief Medical Officer at Treatment.com, encapsulates the vision of the project: “Old data approaches inevitably reflect old biases. Treatment confronts issues of historical bias by reinventing how data about families is collected and stored to reflect the realities of modern life.”

A Call to Investors and Traders

For investors and traders in the healthcare and technology sectors, Treatment.com’s innovative approach represents not just a leap in healthcare equity but also a potentially promising investment opportunity. By addressing long-standing disparities and biases, Treatment.com is not only advancing the field of digital health but also positioning itself as a leader in the rapidly growing market for AI-driven healthcare solutions. As the project moves from prototype to commercialization, the potential for significant impact — both socially and financially — is immense.

In conclusion, Treatment.com’s (CSE: TRUE) culturally sensitive AI initiative for collecting family medical histories is a beacon of innovation in the healthcare sector, promising a future where medical data collection is inclusive, accurate, and reflective of our diverse societies. For traders and investors, this represents a unique opportunity to be part of a venture that is set to redefine the standards of healthcare and medical data analysis in the digital age.

Some of the other Health Care AI related stocks to keep an eye on include NVIDIA Corp (NASDAQ: NVDA), SoundHound AI Inc (NASDAQ: SOUN), Symbotic Inc (NASDAQ: SYM), Upstart Holdings Inc (NASDAQ: UPST), Procept BioRobotics Corp (NASDAQ: PRCT), AeroVironment Inc. (NASDAQ: AVAV), Intuitive Surgical Inc (NASDAQ: ISRG).

Disclaimer: This news article is for information purposes only and is neither a solicitation or recommendation to buy nor an offer to sell securities. The Bull Report is not-a-registered-investment-advisor. The Bull Report is not a broker-dealer. Information, opinions, and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. The Bull Report accepts no liability for any losses arising from an investor’s reliance on the use of this material. Starting on Mar 15, 2024 The Bull Report has been compensated $47,000 per month for coverage of TRUE by Sunburst Capital Corp. The Bull Report and its affiliates or officers may purchase, hold, and sell shares of common stock of this stock, in the open market at any time without notice. The Bull Report will not update its purchases and sales of this stock in any future postings on The Bull Report’s websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words “may”, “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” ” project,” and similar expressions and variations thereof are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *The Bull Report does not set price targets on securities. Never invest in a stock discussed on this website or in this email alert unless you can afford to lose your entire investment.

Sources:

TRUE

https://finance.yahoo.com/quote/TRUE.CN/

https://finance.yahoo.com/news/treatment-ai-passes-medical-school-123000812.html

Media Contact
Company Name: TheBullReport
Contact Person: Jason Roy
Email: info@thebullreport.com
City: Dallas
State: Texas
Country: United States
Website: https://www.thebullreport.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Revolutionizing Medical Histories: Treatment AI\’s (CSE: TRUE) Pioneering Approach to Culturally Sensitive Data Collection

Aurea Vita Advisors Announces Strategic Hire of Industry Veteran Chris Barber

Plasma collection consultants expand leadership team.

Scottsdale, AZ, USA – Aurea Vita Advisors, a leading consulting firm specializing in human blood-plasma collection solutions, announced the addition of Chris Barber to its executive team as Managing Director, International Business effective MAY 01, 2024, further solidifying the firm’s commitment to excellence, innovation, and international expansion in the rapidly evolving plasma-derived therapies industry.

Charles Auger, the CEO and Principal of Aurea Vita Advisors, expressed his enthusiasm about the milestone, highlighting his longstanding relationship with Barber spanning over 25 years. “I have known Chris for over two decades, and am confident that our synergy will create an unparalleled force in the plasma collection consulting space at the global level. Together, we bring a unique blend of skills that will greatly benefit our clients and the patients they ultimately serve.”

In this strategic addition, Chris Barber will focus exclusively on Aurea Vita Advisors’ international business activities and projects, while Charles Auger will continue leading efforts servicing US clients, as well as heading global regulatory matters. This division of responsibilities leverages Chris Barber’s extensive experience as a plasma collection integrator and operator, specializing in expanding and scaling operations, and incorporating new technologies. Meanwhile, Charles Auger excels in navigating governmental regulatory challenges and designing plasma collection organizations to ensure product quality and donor safety.

Aurea Vita Advisors is poised to offer comprehensive solutions for all components of a high-performing plasma collection enterprise worldwide, thanks to the combined expertise of Charles, Chris, and the teams they can deploy. “AVA is positioning with the global industry trend of nations seeking self-sufficiency to protect their citizens, as the demand for plasma-derived therapies is expected to grow at a compelling 8-12% CAGR through 2032,” remarked Barber.

“We believe Chris joining AVA will significantly enhance our ability to provide guidance and management solutions for plasma collection networks worldwide,” stated Auger. “Our shared vision for safe and reliable source plasma and hyperimmune supplies for patients around the world will undoubtedly benefit clients seeking to navigate the complexities of the evolving plasma industry.”

For more information about Aurea Vita Advisors and their comprehensive plasma collection enterprise solutions, please visit www.AureaVitaAdvisors.com.

About Aurea Vita Advisors:

Aurea Vita Advisors is a leading international consulting firm specializing in plasma collection enterprise optimization. With a team of seasoned industry experts, AVA provides comprehensive solutions for organizations seeking to excel in the dynamic and rapidly growing field of plasma-derived therapies.

Media Contact
Company Name: Aurea Vita Advisors
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: www.AureaVitaAdvisors.com

Freelancers HUB Launches as Canada’s Premier Digital Marketing Agency

“Top-Notch Web Design and Digital Marketing Agency in Canada”

We are one of Canada’s best digital marketing agencies, specializing in WordPress web design, SEO, Google AdWords, Facebook advertising, and Social Media Marketing.

London, Ontario, Canada – Freelancers HUB, a dynamic digital marketing company, has been officially launched, aiming to revolutionize the online presence of businesses across Canada. With a focus on innovation and tailored solutions, Freelancers HUB is poised to become the go-to partner for businesses across various industries seeking to enhance their online presence and achieve measurable results.

“The vision is to become Canada’s one of digital marketing agencies by providing economically practical services,” said Shovon Joarder, Founder and CEO of Freelancers HUB. “We are excited to embark on this journey, empowering businesses small or big with customized strategies and exceptional support to thrive online.”

Focusing on expertise, cost-effectiveness, scalability, and a data-driven approach, Freelancers HUB offers a comprehensive suite of services tailored to meet the diverse needs of businesses across various industries. From WordPress web design and development and search engine optimization (SEO) to social media marketing (SMM) and pay-per-click (PPC) advertising, Freelancers HUB provides the expertise and resources necessary to maximize online visibility and drive results.

Freelancers HUB’s services are designed to cater to a wide range of industries, including automobile, coffee shops, restaurants, hotels, local businesses, hair salons, healthcare, service providers, schools, and professional markets.

For more information about Freelancers HUB and its services, visit https://freelancers-hub.ca/

Media Contact
Company Name: Freelancers HUB Canada
Contact Person: Shovon Joarder
Email: Send Email
Phone: +1 (646) 783-0345
City: London
State: Ontario
Country: Canada
Website: https://freelancers-hub.ca

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Freelancers HUB Launches as Canada\’s Premier Digital Marketing Agency

Only 17 Stocks in the S&P 500 Have Outperformed the S&P 500 Index in EACH of the Past 4+ Years

Washington, DC – April 1, 2024 – 17 stocks in the S&P 500 have consistently beaten the performance of the S&P 500 index on an annual basis over each of the last 4 years. At StoxxUSA.org, our equity analysis team has identified these StoxxUSA “Stars” which have beaten their respective index in each of the last 4 years.

Stoxxusa.org

The S&P “Stars” Report is prepared by StoxxUSA.org. StoxxUSA.org is not a registered investment, legal or tax advisor or a broker/dealer. All investment/financial opinions expressed in the S&P “Stars” Report are from the personal research and experience of StoxxUSA.org and intended as educational material. Although best efforts are made to ensure that all information is accurate,

unintended errors and misprints may occur, and we do NOT advise making investment decisions solely off of the contents of this report. The information in this report is not intended as, and shall not be understood or construed as, financial advice. StoxxUSA.org or its employees are not attorneys, accountants, or financial advisors and the information contained in this report is not a substitute for financial advice from a registered advisor.

StoxxUSA.org is a non-profit equity research organization. For more information on StoxxUSA.org, visit our website at https://stoxxusa.org/

Media Contact

Josiah Kettelhake

josiahk@everestcpi.com

StoxxUSA – Weekly Index Performance Updates (Home Page)

Disclaimer

The contents of this press release are for informational purposes only. You should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this press release constitutes a consultation or a solicitation for investment or the purchase or sale of any financial asset. Any investment decision should be made after consulting with a professional about your specific circumstances.

The information provided in this press release does not constitute advice or investment opinion, and it should not be relied upon as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any reader’s particular investment objectives, financial situations, or needs. Readers should not consider it as financial advice and should consult with their financial advisor before making any investment decisions.

Neither the distribution company nor its partners are responsible for any decision made on the basis of this press release. Any decision based on this press release should be made after consulting with a professional. The source of this press release, Stoxxusa, must be contacted for any queries.

Media Contact
Company Name: StoxxUSA.org
Contact Person: Josiah Kettelhake
Email: Send Email
Country: United States
Website: https://stoxxusa.org/

Primary Progressive Multiple Sclerosis Treatment Market Size, Share, Trends, Growth And Forecast To 2032

Primary Progressive Multiple Sclerosis Treatment Market By Drug Type (Approved Drugs, Pipeline Drugs), By Distribution Channel (Retail Pharmacies, E-commerce, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Prominent features of the primary progressive multiple sclerosis treatment market include developments in approved and pipeline medications, the increasing influence of e-commerce in the distribution process, and persistent difficulties faced by conventional retail pharmacies. The market for primary progressive multiple sclerosis treatment is anticipated to expand at a CAGR of 15.1% between 2024 and 2032. Notwithstanding limitations, the market exhibits tenacity and prospects for expansion. The segmentation analysis uncovers dynamic patterns in product preferences and distribution channels, which are shaped by advancements in technology and evolving patient inclinations. Geographically, there are a multitude of opportunities that arise, and the necessity for ongoing research and development is underscored by competitive trends. In the period following 2023 and throughout the forecast period, stakeholders in the primary progressive multiple sclerosis treatment market must effectively manage obstacles and take advantage of developing prospects to guarantee the continuous expansion of this pivotal healthcare sector on a global scale.

Developments in approved pharmaceuticals are a key factor propelling the primary progressive multiple sclerosis treatment market. Pharmaceutical corporations, including Biogen and Roche, have taken the lead in endeavors to augment the effectiveness of currently available medications. For example, ocrelizumab, a drug that has received approval from the FDA, has exhibited encouraging results in clinical trials. This driver is supported by an abundance of empirical research and scientific literature, which demonstrate enhanced patient outcomes and disease management.

Pipeline drug innovations significantly contribute to the evolving landscape of primary progressive multiple sclerosis treatment. Novartis and Sanofi, among other biopharmaceutical firms, are deeply involved in the development of innovative therapeutic alternatives. The driver is substantiated by evidence such as promising outcomes from phase II and III clinical trials, which underscore the potential of nascent pharmaceuticals to tackle unfulfilled medical requirements and offer more precise therapeutic strategies for patients with PPMS.

Browse for report at: https://www.acutemarketreports.com/report/primary-progressive-multiple-sclerosis-treatment-market

The increasing significance of e-commerce in the distribution of pharmaceuticals is a noteworthy factor that has garnered attention in recent times. Digital platforms have significantly transformed the distribution channel for PPMS medications by providing enhanced convenience and accessibility. The increasing adoption of e-commerce channels by pharmaceutical companies, which has improved patient access to medications, particularly during the COVID-19 pandemic, serves as evidence of this driver.

Notwithstanding the expansion of e-commerce, conventional retail pharmacies, and alternative distribution channels continue to face obstacles. Constraints include challenges such as disruptions in the supply chain, restricted accessibility, and the requirement for specialized storage conditions. This limitation is substantiated by well-documented obstacles that patients encounter when attempting to obtain PPMS medications via retail pharmacies and alternative distribution channels, which have an impact on the market dynamics as a whole.

When conducting a segmentation analysis, the category of product is an essential determinant of market dynamics. Approved medications dominated the market and generated the most revenue in 2023. On the contrary, it is projected that pipeline medications will outperform approved drugs in terms of revenue and compound annual growth rate (CAGR) from 2024 to 2032. This transition is supported by results from clinical trials and the expected introduction of novel pipeline medicines to the market.

Get Free Sample Copy From https://www.acutemarketreports.com/request-free-sample/140187

A crucial element of market segmentation, the distribution channel reflects modifications in the manner in which PPMS medications reach patients. Retail pharmacies dominated the drug distribution channel in 2023, generating the most revenue. However, it is anticipated that e-commerce will generate the most revenue and grow at the fastest CAGR from 2024 to 2032, indicating a paradigm shift in the distribution industry.

Geographically, the market for primary progressive multiple sclerosis treatments displays a variety of trends. Asia-Pacific is anticipated to have the maximum CAGR during the period of forecast, due to rising patient awareness, a developing healthcare infrastructure, and increased awareness. Conversely, it is anticipated that North America will retain its status as the region boasting the highest revenue percentage, which signifies a well-established pharmaceutical industry and a mature market.

Prominent entities within the primary progressive multiple sclerosis treatment industry consist of Biogen, Roche, Novartis, Sanofi, Mapi Pharma Ltd., Atara Biotherapeutics, Takeda Pharmaceuticals International, Inc., AB Science, and Mallinckrodt. These corporations are instrumental in influencing market trends using ongoing innovation, strategic alliances, and a commitment to meeting the specific requirements of patients with PPMS. The overarching perspective underscores the sector’s dedication to improving patient care and stresses the necessity of adjusting to changing market conditions.

Media Contact
Company Name: Acute Market Reports, Inc.
Contact Person: Chris Paul
Email: Send Email
Phone: US/Canada: +1-855-455-8662, India: +91 7755981103
Address:90 Church St, FL 1 #3514, New York, NY 10008, USA
City: New York
State: New York
Country: United States
Website: www.acutemarketreports.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Primary Progressive Multiple Sclerosis Treatment Market Size, Share, Trends, Growth And Forecast To 2032

Protein Supplements Market Revenues to Reach USD 36.70 billion by 2028- Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence

According to the latest research report titled, “Protein Supplements Market (2023 – 2028)” by Mordor Intelligence, the Protein Supplements Market is estimated at USD 25.21 billion in 2023 and growing at a CAGR of 7.80% during the forecast period.

Protein supplements are popular among gym fanatics, and fitness enthusiasts, as they influence various aspects of the body such as muscle growth, metabolism, energy levels, heart health, and weight management. The diversity of protein supplements, in terms of claims, protein content, sources, forms, and flavors, is catering to a wide consumer group around the globe and driving the market actively. It is expected to continue gaining momentum during the forecast period as well. Additionally, the increasing demand for plant-based protein is expected to push manufacturers to bring organic and clean-label protein supplements across the market channels.

Report Summary

Market Size (2023): USD 25.21 billion
Market Size (2028): USD 36.70 billion
CAGR (2024 – 2029): 7.80%
Study Period: (2019-2029)
Report Scope: Market Dynamics, Revenue Forecast & Segmentation, Competitive Landscape & Recent Developments, Market Growth, Future Opportunities, and Trends
Market Drivers: Market Diversity & Product Innovation is Propelling Protein Supplement Demand and Growing Fitness and Sports Culture

Which are the Top Companies in the Protein Supplements Market?

The protein supplements market exhibits fragmentation, characterized by the participation of numerous regional and global players. In February 2022, Nestle Health Science, a business unit of Nestle SA, completed its acquisition of Vital Proteins, a Chicago-based manufacturer of collagen-based foods, beverages, and supplements.

Prominent players in the Protein Supplements Market:

Glanbia Plc
Lovate Health Sciences International Inc.
The Hut Group
Scitec Nutrition
Weider Global Nutrition Llc
Abbott Laboratories
Nestle SA
Post Holdings, Inc.
Meiji Holdings Co., Ltd
Mondelez International Inc.

Other Reports that Might be of Your Interest

Europe Collagen Supplements Market Report: The Europe Collagen Supplements Market size is estimated at USD 1.5 billion in 2024, and is expected to reach USD 2.03 billion by 2029, growing at a CAGR of 6.22% during the forecast period (2024-2029)
Collagen Supplements Market Report: The Collagen Supplements Market size is estimated at USD 5.94 billion in 2024, and is expected to reach USD 8.59 billion by 2029, growing at a CAGR of 7.66% during the forecast period (2024-2029)

Key Highlights from the Protein Supplements Market Report

1. Market Diversity and Product Innovation Drive Surge in Protein Supplement Demand

Protein’s popularity spans diverse consumer groups, from athletes seeking performance enhancement to seniors preserving muscle mass and busy individuals opting for convenient meal-replacement protein products like powders, bars, and shakes.
Rising interest in specialty diets such as paleo, ketogenic, and Whole30, which prioritize fat and protein over carbohydrates and sugar, is driving individuals to evaluate their protein intake and explore new sources. This trend is fueling global demand for protein supplements.
The market has become more diverse with the growing consumer base, including people from different genders, age groups, goals, etc.
Companies are developing innovative protein supplements and functional nutrition products in multiple flavors to meet the increasing demand from consumers with diverse health goals, lifestyles, and values.
In March 2022, MusclePharm, a global provider of leading sports nutrition and lifestyle branded nutritional supplements, launched a high whey protein drink line (Ready-To-Drink protein drink) with over 20g of protein in multiple sugar-free flavors.

2. Asia-Pacific Poised for Significant Market Share in Protein Supplement Industry

The Asia-Pacific region is anticipated to capture a significant market share and experience rapid expansion, propelled by a larger proportion of young consumers and growing disposable incomes. China is poised to lead this growth, fueled by governmental efforts promoting sports participation and healthier living among residents. These initiatives aim to position China as a prominent player in the global sports arena. Additionally, the burgeoning popularity and wider accessibility of sports leagues, such as the Chinese Super League and ASEAN Basketball League, are fostering a fitness-oriented culture, driving the demand for protein supplements in China.

What are the Latest Developments in the Protein Supplements Market?

In July 2022: The Dymatize brand of Post Holdings Inc. launched its new plant-based protein supplement named Complete Plant Protein. The product is developed with vegan ingredients like soy protein which contains 25g of protein in every pack.
In July 2022: Glanbia PLC’s Optimum Nutrition commenced manufacturing in India. This marks India as the third manufacturing location for Optimum Nutrition products, which were previously exclusively produced in the United States and the United Kingdom for global distribution. The expansion into India highlights Optimum Nutrition’s commitment to meeting the growing demand for its products in the Indian market and further establishing its global presence.

Mordor Intelligence Report on the Protein Supplements Market segments the market based on product type, application, and geography:

By Form (Market Size & Forecast based on Value (USD billion), 2024-2029)

Powder
5.1.2 Ready to Drink
5.1.3 Bars
Other Forms

By Source (Market Size & Forecast based on Value (USD billion), 2024-2029)

Animal-based
Plant-based

By Distribution Channel (Market Size & Forecast based on Value (USD billion), 2024-2029)

Animal-based
Plant-based

By Geography (Market Size & Forecast based on Value (USD billion), 2024-2029)

North America

United States
Canada
Mexico
Rest of North America

Europe

United Kingdom
Germany
France
Italy
Russia
Spain
Rest of Europe

Asia-pacific

China
Japan
India
Australia
Rest of Asia-Pacific

South America

Brazil
Argentina
Rest of South America

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

In a nutshell, the Mordor Intelligence Market Research Report provides in-depth market insight to industry players, investors, researchers, consultants, and business strategists, looking for comprehensive details on the Protein Supplements Market. Get a glance at the Protein Supplements Market Report (2024 – 2029)

About Mordor Intelligence

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

Other Related Reports that Might be of Interest

Dietary Supplements Market Report: The Dietary Supplements Market size is estimated at USD 139.38 billion in 2024, and is expected to reach USD 173.69 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029)
United Kingdom Probiotics Market Report: The United Kingdom Probiotics Market size is estimated at USD 1.91 billion in 2024, and is expected to reach USD 2.27 billion by 2029, growing at a CAGR of 3.62% during the forecast period (2024-2029)

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Prateeksha Rawat
Email: Send Email
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Protein Supplements Market Revenues to Reach USD 36.70 billion by 2028- Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence

Turbines Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Turbines Market By Product (Hydro, Steam, Gas-based, Wind, Nuclear), By Application (Power Generation, Power Storage, Marine, Aeronautics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The market for turbines is characterized by its dynamic nature, as different product segments and applications are influenced by distinct drivers. The market for Turbines is anticipated to expand at a CAGR of 5.5% between 2024 and 2032. Hydroelectric and wind turbines make substantial contributions towards the achievement of sustainable energy objectives, whereas gas-powered turbines are indispensable for the generation of flexible power. Nevertheless, the nuclear turbine industry continues to face obstacles, which is indicative of the intricate nature of nuclear power. The segmentation underscores the revenue predominance of gas-powered turbines and the exponential expansion of wind turbines within the renewable energy domain. Asia-Pacific emerges as a significant growth region from a geographical standpoint, and the competitive landscape is comprised of genuine market leaders positioned to sustain growth throughout the forecast period. In light of the ongoing transformations in the worldwide energy sector, turbines continue to be indispensable in addressing the varied and growing demands of power generation in various industries and applications.

Hydro turbines have emerged as a significant market catalyst in the turbine industry, serving as a critical component in the generation of sustainable energy. Prominent organizations such as General Electric (GE) and Siemens have played a pioneering role, providing substantial evidence supporting this driver. Hydro turbines have been successfully implemented in diverse hydropower projects worldwide, thereby demonstrating their dependability, effectiveness, and capacity to exploit renewable energy sources; thus, they are making a significant contribution towards a more environmentally sustainable future.

The wind turbine industry is a significant catalyst in the worldwide transition to renewable energy. Prominent entities in this domain include Vestas and Siemens Gamesa, as supported by data demonstrating the exponential expansion of wind energy installations. Wind farms and initiatives situated on land serve as concrete illustrations of the efficacy of wind turbines in harnessing wind energy, mitigating carbon emissions, and offering a sustainable form of electricity generation.

Browse for report at: https://www.acutemarketreports.com/report/turbines-market

The proliferation of gas-powered turbines in the power generation sector is propelling advancements, with Mitsubishi Hitachi Power Systems (MHPS) and Siemens Energy emerging as frontrunners in this regard. This driver is substantiated by the proliferation of gas-powered turbines in power facilities across the globe. These turbines provide the energy sector with adaptability, high efficiency, and rapid startup, thereby satisfying its ever-changing demand for dependable and timely power generation.

Notwithstanding the general expansion of the turbine industry, nuclear turbines encounter obstacles that contribute to a constrained market segment. Prominent corporations such as Areva and Toshiba have confronted obstacles about safety considerations, regulatory complexities, and public opinion matters that are linked to nuclear energy. Concrete evidence suggests that there have been occurrences of project cancellations and delays, which underscores the intricate and constraining nature of the nuclear turbine industry within the worldwide energy domain.

A variety of turbine types are available on the market, including steam, gas-based, wind, and nuclear turbines. Gas-powered turbines generated the most revenue in 2023, owing to their extensive utilization in the generation of electricity. On the contrary, it was wind turbines that demonstrated the most substantial Compound Annual Growth Rate (CAGR) from 2024 to 2032, as projected. Increased global attention towards renewable energy sources, with a particular emphasis on the future function of wind turbines in power generation, is responsible for this expansion.

Get Free Sample Copy From: https://www.acutemarketreports.com/request-free-sample/140188

By application, the market for turbines is additionally divided into Power Generation, Power Storage, Marine, and Aeronautics. Revenues were highest in Power Generation and Aeronautics in 2023, as a result of the widespread application of turbines in aviation and electricity production. In contrast, between 2024 and 2032, Power Storage exhibited the most substantial CAGR, suggesting that turbines are assuming an increasingly significant role in energy storage solutions.

The turbine market demonstrates a wide range of geographic tendencies. Asia-Pacific is anticipated to have the maximum CAGR over the forecast period, driven by escalating energy demands and rapid industrialization, especially in China and India. North America maintains the lead in terms of revenue percentage in 2023, owing to its emphasis on renewable energy initiatives.

Prominent industry participants, such as General Electric (GE), Siemens, Vestas, Mitsubishi Hitachi Power Systems (MHPS), Areva, Toshiba, Siemens Gamesa, Alstom S.A., Ballard Power Systems Inc., and Doosan Fuel Cell America, Inc., engage in fierce competition within the turbines market. These legitimate businesses have positioned themselves strategically by introducing innovative products, forming partnerships, and expanding into international markets. Investing in research and development, forming strategic alliances, and concentrating on sustainable and efficient power solutions are the primary strategies. According to the revenues of the leading companies in 2023, General Electric (GE) and Siemens are at the summit. It is anticipated that these actual companies will maintain their positions between 2024 and 2032, with growth being propelled by the ongoing technological advancements in turbines and the worldwide trend towards sustainable energy solutions.

Other Popular Reports: https://www.acutemarketreports.com/category/machinery-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Turbines Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Artificial Intelligence in Manufacturing Market Set to Reach USD 20.8 Billion by 2028, at a CAGR of 45.6%

“Artificial Intelligence in Manufacturing Market”

The global Artificial Intelligence in Manufacturing Market in terms of revenue was estimated to be worth $3.2 billion in 2023 and is poised to reach $20.8 billion by 2028, growing at a CAGR of 45.6%.

The global Artificial Intelligence (AI) in Manufacturing Market is poised for remarkable growth, with MarketsandMarkets forecasting its value to increase from USD 3.2 billion in 2023 to USD 20.8 billion by 2028. This represents a staggering Compound Annual Growth Rate (CAGR) of 45.6% during the forecast period. These insights are derived from the latest report by MarketsandMarkets, a leading market research and consulting firm.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72679105

Key Segments in the Market:

Technology: The AI in manufacturing market is segmented based on technology into machine learning, computer vision, natural language processing, and context-aware computing, among others.

Application: Key applications of AI in manufacturing include predictive maintenance, quality control, demand forecasting, supply chain optimization, and production planning, among others.

End-User Industry: Major end-user industries leveraging AI in manufacturing include automotive, electronics, aerospace & defense, pharmaceuticals, and food & beverages, among others.

Inquire Before Buying @
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=72679105

Growth Drivers:

Several factors are driving the rapid growth of the global AI in manufacturing market, including:

Increased Efficiency: AI-powered solutions enable manufacturers to optimize processes, reduce downtime, improve product quality, and enhance operational efficiency, thereby driving adoption across the manufacturing sector.

Rising Demand for Automation: Growing demand for automation and smart manufacturing solutions, coupled with advancements in AI technologies, is fueling the adoption of AI-driven solutions in manufacturing processes.

Demand for Predictive Maintenance: The need for predictive maintenance to minimize unplanned downtime and optimize asset performance is driving the adoption of AI-based predictive maintenance solutions in manufacturing industries.

Challenges:

Despite the promising growth prospects, the AI in manufacturing market faces certain challenges, including:

Data Security and Privacy Concerns: The proliferation of AI technologies in manufacturing raises concerns regarding data security, privacy, and the potential misuse of sensitive information.

Integration Complexity: Integrating AI solutions with existing manufacturing systems and processes can be complex and challenging, requiring significant investments in infrastructure and skilled personnel.

View detailed Table of Content here –
https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-manufacturing-market-72679105.html

Opportunities:

The market presents several opportunities for growth, including:

Emerging Applications: Emerging applications of AI in manufacturing, such as autonomous robots, digital twins, and AI-driven supply chain optimization, present lucrative opportunities for market players.

Rapid Technological Advancements: Ongoing advancements in AI technologies, such as deep learning, reinforcement learning, and explainable AI, are opening new avenues for innovation and differentiation in the manufacturing sector.

Key Players:

Leading players in the global AI in manufacturing market include:

IBM Corporation

Siemens AG

Microsoft Corporation

General Electric Company

SAP SE

Intel Corporation

NVIDIA Corporation

Alphabet Inc. (Google)

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-manufacturing-market-72679105.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Artificial Intelligence in Manufacturing Market Set to Reach USD 20.8 Billion by 2028, at a CAGR of 45.6%

Ultrasound Market worth $11.6 billion by 2028 MarketsandMarkets

“GE Healthcare is a leading global medical technology and life sciences company, and a division of General Electric (GE). It is dedicated to providing a wide range of healthcare solutions, including medical imaging, monitoring, and diagnostics. One of its key focus areas is the development and advancement of ultrasound products.”

GE Healthcare is a leading global medical technology and life sciences company, and a division of General Electric (GE). It is dedicated to providing a wide range of healthcare solutions, including medical imaging, monitoring, and diagnostics. One of its key focus areas is the development and advancement of ultrasound products.

Ultrasound Market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $11.6 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include rising patient population, various chronic diseases, and technological advancements along with the increasing adoption of ultrasound for diagnostic imaging.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=467

Technology segment to register significant growth rate over the forecast period of 2023-2028

Based on technology, the global ultrasound imaging market is segmented into diagnostic and therapeutic ultrasound. The therapeutic ultrasound segment is anticipated to register the second highest growth rate over the forecast period. The diagnostic ultrasound segment accounted for the highest share of the ultrasound market in 2022.

Portability segment to register significant growth rate over the forecast period of 2023-2028

Based on the portability, the ultrasound market is segmented into trolly/cart-based ultrasound, compact/handheld ultrasound systems, and POC ultrasound systems. The trolly/cart-based ultrasound segment is anticipated to register the highest growth rate over the forecast period. The compact/handheld ultrasound systems segment accounted for the highest share of the ultrasound market in 2022.

Component segment accounted for the largest share of the ultrasound market, by application in 2022.

Based on component, the global the ultrasound market is segmented into transducers/probes, workstations, other components. Transducer/probes segment accounted for the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.

Factors such as the rising incidence of cancer cases, the growing geriatric population, and the launch of integrated modalities drive the growth of ultrasound products.

The hospital and clinics segment accounted for the largest share of the ultrasound market, by end user, in 2022

Based on end user, the ultrasound market is segmented into hospitals, surgical centres, diagnostic centres, maternity centres, ambulatory centres, research and academia and other end users. The hospitals, surgical centres, diagnostic centres segment accounts for the largest share of the market in 2022. Factors attributing to the share of this particular are increasing cancer incidences and increasing number of dermatological surgeries performed in hospitals and clinics are driving the growth of this segment.

The Asia Pacific market to register a significant growth in the market during the forecast period

The Asia Pacific ultrasound market is estimated to register a significant growth from 2023 to 2028. The increasing patient population, rising geriatric population, rapid economic growth and increasing disposable income are driving the market growth in APAC countries. This region is having a rise in healthcare investment and expenditure, offering significant growth opportunities for the key players.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=467

Key Market Players:

As of 2022, prominent players in the ultrasound market are GE healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Siemens AG (Germany), Fujifilm Corporation (Japan), and Hologic, Inc. (US)

Ultrasound Market Advantages:

Non-Invasive: Ultrasound is a non-invasive imaging technique, meaning it does not require any incisions or exposure to ionizing radiation, making it safer for patients and reducing the risk of complications.
Real-Time Imaging: Ultrasound provides real-time imaging, allowing medical professionals to observe and assess dynamic processes within the body, such as blood flow, organ movements, and fetal development.
Portability: Advancements in technology have led to the development of portable and handheld ultrasound devices, enabling point-of-care imaging in remote or resource-limited settings and increasing accessibility to medical care.
Cost-Effective: Compared to other imaging modalities like MRI or CT scans, ultrasound is generally more cost-effective, making it a cost-efficient choice for both healthcare providers and patients.
No Ionizing Radiation: Ultrasound uses sound waves instead of ionizing radiation, making it a safer option for imaging pregnant women, children, and individuals who require frequent imaging studies.
Wide Range of Applications: Ultrasound has a diverse range of applications across various medical specialties, including obstetrics, gynecology, cardiology, radiology, gastroenterology, and more, making it a versatile tool for healthcare professionals.
Real-Time Guidance: Ultrasound can be used in real-time to guide medical procedures, such as needle biopsies, drain placements, and catheter insertions, increasing accuracy and reducing the risk of complications.
High Patient Tolerance: Patients generally find ultrasound examinations comfortable and painless, contributing to improved patient compliance and satisfaction.
Safe for Repetitive Use: Ultrasound can be used repeatedly without any harm to the patient, making it suitable for monitoring and follow-up examinations.
Accessibility: Ultrasound machines are widely available in medical facilities, from large hospitals to smaller clinics, allowing for prompt and convenient access to imaging services.

Overall, the advantages of ultrasound make it an indispensable tool in modern medicine, facilitating early and accurate diagnoses, improving patient care, and contributing to better health outcomes.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=467

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ultrasound Market worth $11.6 billion by 2028 MarketsandMarkets